C. Natera

1.5k total citations
12 papers, 390 citations indexed

About

C. Natera is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, C. Natera has authored 12 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Applied Microbiology and Biotechnology and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in C. Natera's work include Antibiotic Use and Resistance (5 papers), Nosocomial Infections in ICU (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). C. Natera is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Nosocomial Infections in ICU (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). C. Natera collaborates with scholars based in Spain. C. Natera's co-authors include Jesús Rodríguez‐Baño, Julián Torre‐Cisneros, Fernando Rodríguez-López, Enrique Nuño, Juan E. Corzo, Alfonso del Arco, M. Torres-Tortosa, Marta Herrero, A Arroyo and Raquel Moya and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

C. Natera

12 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Natera Spain	8	180	158	147	138	90	12	390
Jacqueleen Wise United States	7	146 0.8×	203 1.3×	115 0.8×	140 1.0×	87 1.0×	10	399
Kate Sulham United States	10	252 1.4×	257 1.6×	124 0.8×	161 1.2×	121 1.3×	19	487
Jung-Jr Ye Taiwan	15	206 1.1×	170 1.1×	84 0.6×	106 0.8×	92 1.0×	28	495
Patrick McLeroth United States	8	331 1.8×	195 1.2×	100 0.7×	150 1.1×	239 2.7×	12	554
Emese Szilágyi Hungary	11	195 1.1×	109 0.7×	93 0.6×	138 1.0×	46 0.5×	13	420
Sarah J. Janelle United States	5	113 0.6×	119 0.8×	96 0.7×	148 1.1×	91 1.0×	11	364
Myrna Mendoza Philippines	9	195 1.1×	188 1.2×	54 0.4×	100 0.7×	69 0.8×	14	435
Ann E. Lloyd United States	6	245 1.4×	154 1.0×	120 0.8×	218 1.6×	107 1.2×	7	485
Carolina Saffioti Italy	8	269 1.5×	176 1.1×	117 0.8×	140 1.0×	155 1.7×	30	466
Ícaro Boszczowski Brazil	14	199 1.1×	112 0.7×	48 0.3×	160 1.2×	72 0.8×	40	550

Countries citing papers authored by C. Natera

Since Specialization

Citations

This map shows the geographic impact of C. Natera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Natera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Natera more than expected).

Fields of papers citing papers by C. Natera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Natera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Natera. The network helps show where C. Natera may publish in the future.

Co-authorship network of co-authors of C. Natera

This figure shows the co-authorship network connecting the top 25 collaborators of C. Natera. A scholar is included among the top collaborators of C. Natera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Natera. C. Natera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Pérez‐Nadales, Elena, Ángela Cano, Julia Guzmán-Puche, et al.. (2022). Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing Klebsiella pneumoniae (KAPEDIS). BMJ Open. 12(4). e058124–e058124. 5 indexed citations

Cisneros, José Miguel, et al.. (2017). Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case–control study. European Journal of Clinical Microbiology & Infectious Diseases. 37(1). 51–56. 11 indexed citations

Machuca, Isabel, Belén Gutiérrez‐Gutiérrez, Irene Gracia-Ahufinger, et al.. (2017). Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems. Antimicrobial Agents and Chemotherapy. 61(8). 58 indexed citations

Machuca, Isabel, Sara Cantisán, C. Natera, et al.. (2016). Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study. Journal of Antimicrobial Chemotherapy. 71(9). 2606–2611. 8 indexed citations

González-Padilla, Marcelino, Julián Torre‐Cisneros, Lorena López‐Cerero, et al.. (2014). Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 70(3). 905–913. 83 indexed citations

Toro, María Dolores del, I. Nieto, Juan E. Corzo, et al.. (2014). Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures. European Journal of Clinical Microbiology & Infectious Diseases. 33(8). 1439–1448. 25 indexed citations

Retamar, Pilar, María Dolores López-Prieto, C. Natera, et al.. (2013). Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study. BMC Infectious Diseases. 13(1). 344–344. 12 indexed citations

Rodríguez‐Baño, Jesús, María Dolores López-Prieto, Pilar Retamar, et al.. (2010). Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clinical Microbiology and Infection. 16(9). 1408–1413. 88 indexed citations

Natera, C., et al.. (2009). Sobreelevación de tatuaje en un paciente infectado por virus de la inmunodeficiencia humana. Enfermedades Infecciosas y Microbiología Clínica. 27(10). 602–604. 6 indexed citations

10.

Rodríguez‐Baño, Jesús, María Dolores López-Prieto, Pilar Retamar, et al.. (2009). Epidemiology and Clinical Features of Community-Acquired, Healthcare Associated and Nosocomial Bloodstream Infections in Tertiary and Community Hospitals. Clinical Microbiology and Infection. 16(9). 1408–13. 90 indexed citations

11.

Camacho, Ángela, Inés Pérez‐Camacho, Antonio Rivero, et al.. (2009). Usar rifampicina más pirazinamida en profilaxis antituberculosa no incrementa el riesgo de hepatotoxicidad grave en pacientes infectados por virus de la inmunodeficiencia humana: metaanálisis de ensayos clínicos aleatorizados y controlados. Enfermedades Infecciosas y Microbiología Clínica. 28(4). 239–244. 3 indexed citations

12.

Natera, C., et al.. (1976). [Corticotherapy in hemangiomas].. PubMed. 33(2). 311–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact